计算溶液所需的质量、体积或浓度。
为什么选择此级别
提供 ≥96% 纯度，适用于对基线干扰要求严格的色谱和分析工作流程。
储存与运输
2-8°C储存,干燥。低温运输 。请查阅批次 COA 获取详细规格。
质量文档
SDS、COA、产品数据表及规格说明书均可下载。可通过批号查询获取批次 COA。
文献证明
在色谱分析、有机合成和交叉偶联反应领域已被 0 篇同行评审文献引用。
概述
Vabicaserin hydrochloride is a 5-hydroxytryptamine 2C ( 5-HT 2C ) receptor -selective agonist with an EC 50 of 8 nM.
In Vitro
Vabicaserin displaces 125 I-(2,5-dimethoxy)phenylisopropylamine binding from human 5-HT 2C receptor sites in Chinese hamster ovary cell membranes with a K i value of 3 nM and is >50-fold selective over a number of serotonergic, noradrenergic, and dopaminergic receptors. Binding affinity determined for the human 5-HT 2B receptor subtype using [ 3 H]5HT is 14 nM. Vabicaserin is a potent and full agonist (EC 50 , 8 nM; E max , 100%) in stimulating 5-HT 2C receptor-coupled calcium mobilization and exhibits 5-HT 2A receptor antagonism and 5-HT 2B antagonist or partial agonist activity in transfected cells, depending on the level of receptor expression. Vabicaserin exhibits lower affinity at the 5-HT 2C antagonist binding site (22 nM) labeled with [ 3 H]mesulergine. Additional binding studies indicate that Vabicaserin possesses affinity for the 5-HT 2B and 5-HT 1A receptors with K i values of 14 and 112 nM, respectively. MCE has not independently confirmed the accuracy of these methods. They are for reference only.
In Vivo
After a single oral dose of [ 14 C]Vabicaserin at 50, 5, and 15 mg/kg, unchanged drug represents less than 19, 20, and 35% of total plasma radioactivity at all the time points examined in mice, rats, and dogs, respectively. The carbamoyl glucuronide (CG) represents approximately 7 to 36% of plasma radioactivity in mice and 2 to 28% of plasma radioactivity in dogs but is not detected in rat plasma after the single [ 14 C]Vabicaserin dose. However, the CG is observed in rat plasma after multiple-dose administration of Vabicaserin at higher doses, and the CG is approximately 20 times less than Vabicaserin based on steady-state AUC 0-24 values. The estimated plasma AUC 0-24 ratios of CG to the parent drug are 1.5 and 1.7 in mice and dogs after the single [ 14 C]Vabicaserin dose, respectively. The plasma AUC 0-24 ratios for the CG to Vabicaserin at steady state with doses used for safety assessment are less for mice (0.2-0.6) and slightly higher for dogs (1.8-4.0) compared with the single dose values. The CG is detected in dog urine in similar amounts to the parent drug, although it is not detected in mouse or rat urine after the single [ 14 C]Vabicaserin dose. Radioactivity in a 0- to 24-h bile collection from rats receiving a 5 mg/kg [ 14 C]Vabicaserin dose accounts for 19 and 24% of the administered dose in males and females, respectively. Although the CG is not detected in urine or feces of rats after a single oral administration, it represents an average of up to 30% of biliary radioactivity in male rats and 15% in female rats. In monkeys after a single oral 25-mg/kg dose of Vabicaserin, the plasma concentrations of the CG exceeded those of Vabicaserin at all the time points (2-24 h) postdose, although the amount of CG relative to Vabicaserin decreased by 24 h postdose, with ratios of 17.5 at 2 h and 1.7 at 24 h. The CG to Vabicaserin AUC 0-24 ratio of 12:1 indicates that the CG is a major metabolite in monkeys. MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Animal administration
Mice and Rats For metabolism studies in mice, rats, and dogs, radiolabeled doses are used. Male and female CD-1 mice and Sprague-Dawley rats are used. The dose vehicle for mice and rats contained 2% (w/w) Tween 80 and 0.5% methylcellulose in water. Nonfasted male and female mice weighing from 27.8 to 33.8 g at the time of dosing are given a single 50-mg/kg (∼300 μCi/kg) dose of Vabicaserin at a volume of 20 mL/kg via intragastric gavage . Mice are kept in metabolic cages in groups of five. Nonfasted male rats weighing from 318 to 345 g and female rats weighing from 227 to 255 g at the time of dosing are given a single 5-mg/kg (∼300 μCi/kg) dose of Vabicaserin at a volume of 2.5 mL/kg via intragastric gavage . Four bile duct-cannulated male rats weighing from 387 to 411 g and four bile duct-cannulated female rats weighing from 291 to 325 g at the time of dosing are nonfasted and are given a single 5-mg/kg (323 μCi/kg) dose of Vabicaserin at a volume of 5.0 mL/kg via intragastric gavage . Rats are kept individually in metabolism cages . Dogs Four male beagle dogs , weighing from 7.6 to 9.8 kg at the time of dosing, are from an in-house colony. Approximately 11 mg of [ 14 C]Vabicaserin hydrochloride and 940 mg of nonlabeled Vabicaserin hydrochloride are dissolved in methanol and then evaporated under a nitrogen stream to dryness. Capsules (number 2) are filled with accurate amounts (126.7-138.1 mg) of the mixed drug substance according to animal weights to give a dosage of 15 mg/kg (39 μCi/kg). The filled gelatin capsules are then enteric-coated manually. Each dog is given one enteric-coated capsule containing [ 14 C]Vabicaserin as the hydrochloride salt. Animals are fed 2 h before dosing and are housed individually in metabolic cages . Monkey Four male cynomolgus monkeys , weighing from 5.4 to 9.6 kg at the time of dosing, are from an in-house colony. Nonfasted monkeys are given a single 25-mg/kg dose of nonradiolabeled Vabicaserin at a volume of 2 mL/kg via intragastric gavage . The vehicle is the same as used in mice and rats. Animals are housed individually in metabolic cages . aladdin has not independently confirmed the accuracy of these methods. They are for reference only.
Form:Solid
IC50& Target:5-HT 2C Receptor 8 nM (EC 50 )
规格
别名
盐酸伐比卡塞林
英文别名
(12R,16S)-7,10-diazatetracyclo[8.6.1.05,17.012,16]heptadeca-1,3,5(17)-triene;hydrochloride | 887258-94-8 (HCl) | DTXSID70977679 | CYCLOPENTA(4,5)PYRIDO(3,2,1-JK)(1,4)BENZODIAZEPINE, 4,5,6,7,9,9A,10,11,12,12A-DECAHYDRO-, HYDROCHLORIDE (1:1), (9AR,12AS)- |
规格或纯度
≥96%
英文名称
Vabicaserin hydrochloride
生化机理
盐酸伐比卡西林是一种 5- 羟色胺 2C （5-HT 2C）受体选择性激动剂，EC 50 为 8 nM。
储存条件
2-8°C储存,干燥
运输条件
低温运输
作用类型
激动剂
作用机制
羟色胺 2a（5-HT2a）受体拮抗剂
纯度
≥96%
名称和识别符
PubChem SID
EC号
618-208-0
分子类型
小分子
IUPAC Name
(12R,16S)-7,10-diazatetracyclo[8.6.1.05,17.012,16]heptadeca-1,3,5(17)-triene;hydrochloride
INCHI
1S/C15H20N2.ClH/c1-3-11-9-16-7-8-17-10-12-4-2-5-13(12)14(6-1)15(11)17;/h1,3,6,12-13,16H,2,4-5,7-10H2;1H/t12-,13-;/m0./s1
InChi Key
PYPPENBDXAWXJC-QNTKWALQSA-N
Smiles
C1CC2CN3CCNCC4=C3C(=CC=C4)C2C1.Cl
Isomeric SMILES
C1C[C@H]2CN3CCNCC4=C3C(=CC=C4)[C@H]2C1.Cl
关联CAS
PubChem CID
分子量
264.79
技术文档
高级数据
系统学分类
分类树（Taxonomy Tree）
-
界（kingdom)
有机化合物
-
超类（Superclass)
有机杂环化合物
-
类（Class)
苯二氮卓类药物
- 亚类（Subclass） 1,4-苯二氮卓类药物
-
类（Class)
苯二氮卓类药物
-
超类（Superclass)
有机杂环化合物
| 界（kingdom) | 有机化合物 |
|---|---|
| 超类（Superclass) | 有机杂环化合物 |
| 类（Class) | 苯二氮卓类药物 |
| 亚类（Subclass） | 1,4-苯二氮卓类药物 |
| 中间层级节点（Intermediate Tree Nodes） | 暂无 |
| 直接上位类(Direct Parent) | 1,4-苯二氮卓类药物 |
| 其他上位类（Alternative Parents） | 氢化喹啉 二烷基芳胺 芳烷基胺 苯类化合物 二烷基胺 氮杂环化合物 盐酸盐 碳氢化合物衍生物 |
| 分子骨架（Molecular Framework) | 芳香族杂多环化合物 |
| 取代基（Substituents） | 1,4-苯并二氮杂卓 - 氨基酸 - 芳烷基胺 - 芳香族杂多环化合物 - 氮杂环 - 苯基化合物 - 二烷基芳基胺 - 烃衍生物 - 氟氯烃 - 有机硝基化合物 - 有机氮化合物 - 二级脂肪胺 - 醛基 - 三级脂肪族/芳香族胺 - 三芳基胺 - 四氢喹啉 |
| 描述（Description） | 该化合物属于有机化合物中的1,4-苯并二氮杂卓类。这类化合物含有与1,4-氮杂卓环并联的苯环结构。 |
| 外部描述符（External Descriptors） | 暂无 |
三维结构
交互式化学结构模型
化学和物理性质
溶解性
DMSO : 60 mg/mL (226.59 mM; ultrasonic and warming and heat to 80°C) H2O : 4 mg/mL (15.11 mM; Need ultrasonic)
敏感性
对湿度敏感
分子量
264.790 g/mol
XLogP3
氢键供体数Hydrogen Bond Donor Count
2
氢键受体数Hydrogen Bond Acceptor Count
2
可旋转键计数Rotatable Bond Count
0
精确质量Exact Mass
264.139 Da
单同位素质量Monoisotopic Mass
264.139 Da
拓扑极表面积Topological Polar Surface Area
15.300 Ų
重原子数Heavy Atom Count
18
形式电荷Formal Charge
0
复杂度Complexity
291.000
同位素原子数Isotope Atom Count
0
定义的原子立体中心计数Defined Atom Stereocenter Count
2
未定义的原子立体中心计数Undefined Atom Stereocenter Count
0
定义的键立体中心计数Defined Bond Stereocenter Count
0
未定义的键立体中心计数Undefined Bond Stereocenter Count
0
所有立体化学键的总数The total count of all stereochemical bonds
0
共价键合单元计数Covalently-Bonded Unit Count
2
安全和危险性（GHS）
质检证书（CoA,COO,BSE/TSE 和分析图谱)
C of A & Other Certificates(BSE/TSE, COO):
输入批号以搜索分析图谱:
通过匹配包装上的批号来查找并下载产品的 COA，每批产品都进行了严格的验证，您可放心使用！
| 批号(Lot Number) | 证书类型 | 货号 |
|---|---|---|
 J2423631 |
分析证书 | V649048 |
| J2423632 |
分析证书 | V649048 |
| J2423633 |
分析证书 | V649048 |
| J2423634 |
分析证书 | V649048 |
| J2423635 |
分析证书 | V649048 |
| J2423636 |
分析证书 | V649048 |
| J2423637 |
分析证书 | V649048 |
| J2423638 |
分析证书 | V649048 |
| J2423639 |
分析证书 | V649048 |
| J2423640 |
分析证书 | V649048 |
| J2423641 |
分析证书 | V649048 |
| J2423642 |
分析证书 | V649048 |
溶液计算器
产品仅提供给经过验证的企业、机构和合格的专业人员用于研发。不适用于人类、动物、诊断或治疗。
Copyright © 2023至今 上海阿拉丁生化科技股份有限公司 保留所有权利。
危险品化学品经营许可证（带存储）